GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Cyclically Adjusted Price-to-FCF

American Cryostem (American Cryostem) Cyclically Adjusted Price-to-FCF : (As of May. 15, 2024)


View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


American Cryostem Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for American Cryostem's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Cyclically Adjusted Price-to-FCF Chart

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of American Cryostem's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, American Cryostem's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Cryostem's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where American Cryostem's Cyclically Adjusted Price-to-FCF falls into.



American Cryostem Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

American Cryostem's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2022 is calculated as:

For example, American Cryostem's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2022 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2022 (Change)*Current CPI (Jun. 2022)
=-0.003/125.0168*125.0168
=-0.003

Current CPI (Jun. 2022) = 125.0168.

American Cryostem Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201209 -0.003 97.633 -0.004
201212 -0.008 96.871 -0.010
201303 -0.011 98.209 -0.014
201306 -0.010 98.518 -0.013
201309 -0.011 98.790 -0.014
201312 -0.008 98.326 -0.010
201403 -0.010 99.695 -0.013
201406 -0.003 100.560 -0.004
201409 -0.005 100.428 -0.006
201412 -0.005 99.070 -0.006
201503 -0.004 99.621 -0.005
201506 -0.004 100.684 -0.005
201509 -0.001 100.392 -0.001
201512 -0.001 99.792 -0.001
201603 -0.008 100.470 -0.010
201606 -0.002 101.688 -0.002
201609 -0.005 101.861 -0.006
201612 -0.001 101.863 -0.001
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.008 104.136 0.010
201712 0.000 104.011 0.000
201803 0.004 105.290 0.005
201806 -0.008 106.317 -0.009
201809 -0.004 106.507 -0.005
201812 -0.003 105.998 -0.004
201903 -0.005 107.251 -0.006
201906 -0.002 108.070 -0.002
201909 -0.001 108.329 -0.001
201912 -0.005 108.420 -0.006
202003 -0.001 108.902 -0.001
202006 -0.002 108.767 -0.002
202009 -0.002 109.815 -0.002
202012 -0.001 109.897 -0.001
202103 -0.003 111.754 -0.003
202106 -0.002 114.631 -0.002
202109 -0.001 115.734 -0.001
202112 -0.010 117.630 -0.011
202203 -0.002 121.301 -0.002
202206 -0.003 125.017 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


American Cryostem  (OTCPK:CRYO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


American Cryostem Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of American Cryostem's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915